Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
31 March 2026
Umicore opens Shanghai innovation center
New 3,600 sqm Shanghai innovation center, first corporate R&D outside Europe; focuses on fuel cells and recycling, expanding to catalysis for renewables, CO2 capture, H2, and local partnerships.
31 March 2026
Topsoe signs FEED deal with Hynfra for Jordan green ammonia
FEED underway for Jordan green ammonia: synthesis tech will convert green H2 to ammonia, avoiding >200,000 t CO2e/yr. FID expected 2027; plant to start 2030; exports planned.
30 March 2026
Golden Pass LNG (QatarEnergy/ExxonMobil) achieves first LNG production
First LNG produced from Train 1 of the 18 mtpa Sabine Pass project, enabling sustained liquefaction and paving way for first cargo and full exports beginning Q2 2026.
30 March 2026
Dow’s Carbon Footprint Ledger wins 2026 CIO 100 Award
Recognized for enabling verifiable PCF certificates, optimizing low‑GHG production pathways, and integrating supply‑chain, sustainability and finance data to scale trusted low‑carbon product offerings.
30 March 2026
Merck enlicitide decanoate, an oral PCSK9 inhibitor, reduces LDL‑C more than guideline non‑statins at 8 weeks
Phase 3 CORALreef AddOn: enlicitide lowered LDL‑C 64.6% at 8 weeks; 78.2% achieved ≥50% reduction and LDL‑C <55 mg/dL; safety comparable to oral non‑statins; FDA CNPV awarded
30 March 2026
LKAB raises mineral resources by 900 million tonnes to 7.2 billion tonnes
Exploration added volume and confidence; reserves ~0.9 Gt. Resources grew mainly at Malmberget; Per Geijer hosts 2.2 Mt REO in situ and phosphorus. EU strategic status granted.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
30 March 2026
Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF
FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
30 March 2026
Iberdrola awards €3.5bn contracts for Eastern Green Link 4 HVDC subsea interconnector
Contracts awarded for a 640 km HVDC subsea link (2,000 MW) between Scotland and England, supplying 1.5M+ homes; construction starts 2028, commissioning 2033; part of wider UK grid investment.
30 March 2026
TotalEnergies completes UK North Sea merger with NEO NEXT
Merger completed; combined group renamed; one party holds a 47.5% stake. It becomes the largest independent producer on the UK Continental Shelf, with 2026 output >250,000 boe/d.
30 March 2026
Itabus fleet adopts Enilive HVO
Entire 100-vehicle fleet runs on HVO made from waste, cutting CO2eq by 79.5%. In 2025 it logged 20M km, used over 3M L HVO (53% avg, 75% peak in Dec).
30 March 2026
UBE obtains food-contact approval for UBECycle recycled PE/PA films
Accredited migration testing plus RecyClass‑certified recycling (following Paulowsky acquisition) confirm regulatory compliance and open use of mechanically recycled PE/PA in regulated packaging.
30 March 2026
GSK's bepirovirsen accepted for regulatory review in China for chronic hepatitis B
China NMPA accepted NDA for bepirovirsen after Phase III B-Well trials showed significant functional cure rates in treated CHB patients; granted Breakthrough Therapy; acceptable safety.
30 March 2026
GSK’s Exdensur approved in China for severe eosinophilic asthma
First ultra-long-acting IL-5 biologic for eosinophilic severe asthma; twice-yearly dosing cut annual exacerbations by ~48–58% in SWIFT trials and lowered hospital/ED visits.
29 March 2026
Merck: WINREVAIR Phase 2 CADENCE shows proof‑of‑concept in CpcPH‑HFpEF
Met primary endpoint with significant PVR reduction at 24 weeks vs placebo. Also favorable mPAP/PAWP, NT‑proBNP and 6MWD trends, delayed clinical worsening; safety consistent with known profile.
28 March 2026
Takeda’s Zasocitinib: Once‑daily pill achieves rapid, durable clearance in plaque psoriasis
Phase 3: ~70% reached sPGA 0/1 at week 16; PASI90 up to 61%, PASI100 up to 33%. Responses rose through week 24 and >90% of responders maintained effect to week 60. Safety consistent with prior studies
28 March 2026
Johnson & Johnson STEMI-DTU RCT: LV unloading with delayed reperfusion does not increase infarct size
Neutral trial. 30‑min Impella improved pre‑PCI TIMI flow. Age 61+ trended smaller infarcts. More bleeding/vascular events but no higher 12‑month mortality. Elevated lactate predicted larger infarcts.
28 March 2026
Johnson & Johnson: ICOTYDE (icotrokinra) 52‑week data show sustained skin clearance and favorable safety
ICONIC Phase 3: PASI100 rose to 49%/48% (ADVANCE 1/2) by Week52; placebo switchers matched. Adolescents: 57% PASI100, 86% PASI90 at 52w. No new safety signals; fewer AEs vs deucravacitinib.
28 March 2026
Lilly: Taltz + Zepbound superior to Taltz alone in psoriatic arthritis with obesity
Phase 3b TOGETHER‑PsA: combination therapy improved ACR50, MDA, fatigue, function, QoL and cardiometabolic markers; 36‑week primary endpoint met (ACR50+≥10% weight loss 31.7% vs 0.8%).
27 March 2026
Sasol — Middle East developments and business impact
Middle East conflict disrupted gas supply - ORYX GTL shut; ~60 staff safe. Fuel and chemicals impacted; Secunda/Natref secure inventories and alternative crude; contingencies active.
27 March 2026
Lilly's EBGLYSS: durable 4‑year control in moderate‑to‑severe atopic dermatitis
Up to four years of monthly maintenance produced durable skin clearance (EASI‑75 94%, EASI‑90 75%, IGA 0/1 68%), itch relief (Pruritus NRS≤4: 78%), 80% without topical steroids; safety consistent.
27 March 2026
Rompetrol Rafinare completes Petromidia and Vega turnarounds
Mechanical works finished; refineries return to staged full capacity after 700+ maintenance jobs, 6 catalyst swaps, ~900 equipment checks and ~1,200 pipeline tests; authorizations recertified.
27 March 2026
Iberdrola/ScottishPower advances 960 MW East Anglia TWO offshore wind project
€4.5bn project progressing; offshore substation foundations in production; visited by UK Energy Secretary. Will power nearly 1 million homes and support skilled jobs.
27 March 2026
LKAB cuts Kiruna production
Changing rock conditions force temporary shutdown of pellet plant KK3 Apr–Nov, cutting ~2 Mt deliveries in 2026. No layoffs; plant gets maintenance; other mine areas assessed; restart aimed 2027.
27 March 2026
RWE approved for Nordseecluster B offshore wind farm
Planning approval granted for Nordseecluster B, adding 900 MW to reach 1.6 GW (660 MW A under construction). Full output ~6.5 TWh/yr; B due early 2029; 110 MW PPA with Amazon.
27 March 2026
GSK bepirovirsen accepted for EMA review for chronic hepatitis B
EMA accepted bepirovirsen MAA for chronic hepatitis B after Phase III B‑Well 1/2 showed higher functional cure rates vs standard of care; safety profile acceptable.
27 March 2026
Avangrid completes 250,000-panel Tower Solar installation in Oregon
120 MWac plant due online this year; panels built by SEG Solar in Houston. Will feed PGE grid and support a QTS data center; construction created 200+ local jobs and ~$20M economic benefit.
26 March 2026
ADNOC and OMV appoint executive team for Borouge Group International AG
Roger Kearns, Dr. Stefan Doboczky and Dr. Hasan Karam to lead; interim CFO until May 2026; supervisory board set; deal on track to close by end‑March 2026, forming a global polyolefins leader
26 March 2026
FDA approves Novo Nordisk Awiqli, first once-weekly basal insulin for adults with type 2 diabetes
ONWARDS trials (~2,680 pts) showed A1C reductions vs daily basal; safety aligned with class. Key risks: hypoglycemia, injection-site reactions, weight gain. US launch pending
26 March 2026
Novo Nordisk gains US approval for Awiqli, first once‑weekly basal insulin for adults with type 2 diabetes
ONWARDS phase‑3 (~2,680 adults) showed HbA1c reductions vs daily basal insulin with similar safety. US launch planned H2 2026; also approved in EU and 13 other countries.
26 March 2026
Arkema builds recyclable speed board for Zephir record attempts
Eco-designed speed board uses recyclable liquid thermoplastic resin with recycled carbon fiber and matching foam, delivering thermoset-like performance, precision and full chemical recyclability.
Next →
